Newtyn Management, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Theravance Biopharma, Inc. Ordinary Share $0.00001 par value (TBPH)

Filing Manager
Newtyn Management, LLC
Reporting Manager
Newtyn Management, LLC
Security
Theravance Biopharma, Inc. Ordinary Share $0.00001 par value
Symbol
TBPH
Shares outstanding
50,588,235 shares
Disclosed Ownership
4,300,000 shares
Ownership
8.5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:15:25 UTC
Date of event
31 Dec 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Newtyn Management, LLC 8.5% 4,300,000 4,300,000 0 /s/ Eugene Dozortsev Eugene Dozortsev, Authorized Signatory
Newtyn TE Partners, LP 5.3% 2,678,900 2,678,900 0 /s/ Eugene Dozortsev Eugene Dozortsev, Authorized Signatory of Newtyn Management, LLC, the Investment Manager